Developer docs
API playgroundTry for free, no card

Search company profiles

BioTuring

Full company profile

uuid0002obx

Namestring
BioTuring
Legal namestring
BioTuring, Inc.
Websiteurl
bioturing.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

BioTuring, Inc. is a San Diego-based bioinformatics software company founded in 2016 that develops an integrated ecosystem of platforms for single-cell, multi-omics, and spatial biology data analysis. Its product family includes BBrowserX Pro for large-scale single-cell RNA-seq analysis (handling 10M+ cells), SpatialX for spatial transcriptomics and proteomics, Talk2Data (a GPU-accelerated database of 500M+ curated single cells with natural-language agentic AI queries and Model-Context-Protocol interoperability on NVIDIA Blackwell B200 infrastructure), SmartBulk for bulk RNA-seq, BioVinci for visualization, BioStudio as an all-in-one notebook platform, BioTuring Lens for spatial deconvolution, and the BioFlex Python SDK for programmatic access. Underlying technology combines proprietary deep-learning algorithms (Venice, IC-VAE, MetaReference, AlphaSC) with multi-stage data curation pipelines standardized on EBI Cell Ontology, Mondo Disease Ontology, and UBERON.

The company serves individual academic researchers, postdoctoral fellows, and professors at universities and academic medical centers (Chiba University, Stanford Medicine, MD Anderson, University of Tokyo, CWRU, University of Hawaii) alongside enterprise customers including pharmaceutical companies (Sanofi, via the Sanofi Browser on Talk2Data for neurodegenerative disease datasets) and biotech services firms (Argentys). BioTuring is certified to ISO/IEC 27001 (2019) and ISO/IEC 27701 (2022).

BioTuring generates revenue primarily through annual software subscriptions across multiple Subscription Levels (SaaS, private-cloud, on-premise), tiered project-based data curation services (price tiers from under $20k to over $1M covering spatial, single-cell, pathology, bulk, and ATAC-Seq annotation), and professional services for implementation, training, and support. Go-to-market blends a product-led growth motion with free trials and self-serve access for individual researchers, complemented by enterprise field sales for pharmaceutical and large research institution contracts. The company is privately held, CEO-led by Son Pham, with only $1,020,677 in disclosed funding from October 2017.

Short descriptiontext

BioTuring is a San Diego bioinformatics software company (founded 2016) that sells an integrated ecosystem of platforms — BBrowserX Pro, SpatialX, Talk2Data, and SmartBulk — for single-cell, multi-omics, and spatial biology analysis, serving academic researchers and pharmaceutical enterprises globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
single-cell analysis software, spatial biology platform, multi-omics data analysis, bioinformatics visualization tools, RNA sequencing analytics
Industry3 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Bioinformatics Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Software Subscriptions
TypeSubscription Recurring
Description

BioTuring grants customers limited, non-exclusive, non-transferable, non-sublicensable subscription rights to access and use the software platforms (BBrowserX, SpatialX, Talk2Data, SmartBulk, BioVinci) during a defined subscription term. Subscriptions are assigned to specific customer or Authorized User accounts and may include various Subscription Levels with different feature entitlements, user counts, storage parameters, and support scope. Fees are non-cancellable and non-refundable once paid, with invoices due within 30 days.

bioturing.com
2Professional Services
TypeProfessional Services
Description

Implementation, onboarding, maintenance, support, training, hosting, migration, storage, compute, and related professional or technical services provided under separate Order Forms. Custom implementations, bespoke onboarding, and expanded support scope are billed separately through Order Forms.

bioturing.com
3Data Curation Services
TypeProfessional Services
Description

Tailored data curation solutions for biological data including radiological imaging, spatial omics, single-cell annotation, pathology image annotation, bulk annotation, and ATAC-Seq curation. Pricing is project-based with tiers: <$20k, $20k-100k, $100k-1M, $1M+.

bioturing.com
4Trial Services
TypeFreemium
Description

Trial, proof-of-concept, sandbox, pilot, evaluation, or no-charge access to software or services provided for customer internal evaluation purposes. Trial services are modified or limited at BioTuring's discretion and do not include service commitments or enhanced support obligations.

bioturing.com
5Data Storage Services
TypeSubscription Recurring
Description

Right to store and process Customer Data in specified amounts and retention profiles as identified in Order Forms or Subscription plans, with additional storage billed separately.

bioturing.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details3 tiers
1Data Curation Services - Project Budget Tiers
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Four project budget tiers available: <$20k, $20k-100k, $100k-1M, $1M+. Pricing varies based on data type (spatial annotation, single-cell curation, pathology image annotation, bulk annotation, ATAC-Seq curation) and project complexity.

bioturing.com
2Subscription Levels
ModelSubscriptionBilling cadenceAnnual
Notes

Multiple Subscription Levels available with different feature entitlements, user counts, deployment models (SaaS, private-cloud, on-premise), storage parameters, usage limits, and support scope. Subscriptions are assigned to specific customer accounts and may not be reassigned or pooled mid-term.

bioturing.com
3Trial Services
ModelFreemiumBilling cadencePay-as-you-go
Notes

No-charge trial access for customer internal evaluation purposes. BioTuring determines available products, features, Authorized User count, Data Storage Services, support scope, and retention period at its discretion. Does not include service commitments or enhanced support obligations.

bioturing.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 8 records shown
1BBrowserX Pro
Description

An all-in-one platform for analysis of single-cell RNA-sequencing data with advanced tools for cell type annotation, DGE analysis, and cell-cell communication

bioturing.com
+7 more records
Core offering1 text field

BioTuring develops and sells a suite of bioinformatics software platforms for analyzing single-cell, spatial, and bulk RNA-sequencing data. Its core offerings include BBrowserX Pro for large-scale single-cell analysis, SpatialX for spatial biology data, Talk2Data as a GPU-accelerated database of 500M+ curated single cells, and SmartBulk for bulk RNA-seq analysis, complemented by professional data curation services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Handles giga-scale studies exceeding 10M cells while staying responsive
+3 more records
Product overview1 text field

BioTuring offers a unified ecosystem of bioinformatics platforms and services for multi-omics and spatial biology analysis. The core portfolio includes BBrowserX Pro for large-scale single-cell RNA-sequencing analysis (handling 10M+ cells), SpatialX for spatial biology data analysis with cell annotation, Talk2Data as a GPU-accelerated database of 500M+ curated single-cell profiles with natural language AI queries, and SmartBulk for bulk RNA-sequencing analysis. Additional products include BioVinci for visualization, BioStudio as an all-in-one bioinformatics platform, BioTuring Lens for spatial deconvolution, and the BioFlex SDK for programmatic access. The ecosystem is complemented by data curation services including spatial annotation, single-cell annotation, pathology image annotation, bulk annotation, and ATAC-Seq annotation. The company holds ISO/IEC 27001 and ISO/IEC 27701 certifications and has partnered with industry leaders including Sanofi for the Sanofi Browser collaboration on Talk2Data.

Product and service6 records
1BBrowserX Pro
CategorySingle-cell analysis software
Description

An all-in-one platform for analyzing single-cell RNA-sequencing data, handling giga-scale studies exceeding 10M cells with integrated annotation, automated cell type prediction, differential gene expression analysis, pathway enrichment, cell-cell communication analysis, pseudotime/trajectory analysis, and cancer cell prediction modules. Designed for biomedical researchers and scientists.

2SpatialX
CategorySpatial biology analysis software
Description

A platform for analyzing spatial biology data with cell annotation, enabling exploration of spatial transcriptomics data within tissue architecture context. Features a Windows-based, non-coding interface allowing biologists to interpret spatial data and understand cell-to-cell interactions at single-cell transcriptomics level.

3Talk2Data
CategoryMulti-omics database platform
Description

A GPU-accelerated multi-omics database providing real-time analysis of 500M+ curated single cells across multiple omics layers. Features natural language queries with agentic AI trained on biomedical knowledge, BioFlex SDK for programmatic access, and Model-Context-Protocol interoperability for AI agent integration.

4SmartBulk
CategoryBulk RNA-seq analysis software
Description

An intuitive platform for analyzing bulk RNA-sequencing data, enabling identification of differentially expressed genes, enriched pathways, sample clustering, and cell-type deconvolution. Includes PCA analysis and functional enrichment capabilities.

5BioFlex SDK
CategoryDeveloper SDK / API
Description

A Python-based software development kit providing programmatic access to Talk2Data datasets, enabling execution of analyses and embedding BioTuring platform capabilities into custom computational pipelines.

6Data Curation Services
CategoryProfessional data curation services
Description

Professional data curation services including Spatial Annotation Service, Single-Cell Annotation Service, Pathology Image Annotation Service, Bulk Annotation Service, and ATAC-Seq Annotation Service. Services organize, normalize, and annotate biological data using standardized ontologies for downstream analysis. Priced by project budget tiers from under $20k to over $1M.

Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

BioTuring hosts the Sanofi Browser on its Talk2Data platform, providing access to Sanofi's published single-cell transcriptomic datasets (5 studies with 297,364 cells total) focused on neurodegenerative disease research including ALS, multiple sclerosis, and Parkinson's disease models. The collaboration enables researchers to explore Sanofi's published datasets including microglia ferroptosis studies (Ryan et al.), BTK inhibitor research (Gruber et al.), and RIPK1 signaling studies in ALS (Zelic et al.).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor in single-cell and bulk RNA-seq analysis software. Now owned by Illumina, Partek offers FlowJo and Partek Flow with similar cell-type annotation, DGE, and visualization capabilities targeted at bench scientists without heavy coding requirements.

TypeDirect peer
Description

Direct peer in GUI-driven omics analysis software for life sciences. Qlucore offers multi-omics, single-cell, and spatial visualization tools with a similar non-coding positioning aimed at biologists and translational researchers.

TypeDirect peer
Description

Scientific informatics platform serving biology R&D with data analysis, visualization, and ELN capabilities. Overlaps with BioTuring on multi-omics data analysis and pharma/biotech enterprise workflows, with broader lab informatics scope.

TypeDirect peer
Description

Cloud-based single-cell RNA-seq analysis platform directly competing with BBrowserX Pro. Acquired by Parse Biosciences, Biomage targets bench scientists with no-code analysis workflows similar to BioTuring's positioning.

TypeEmerging player
Description

Cloud-native bioinformatics platform offering data management, analysis pipelines, and AI tools for multi-omics and biomedical data. Overlaps with BioTuring's Talk2Data and BioStudio offerings with a stronger developer/AI-agent focus.

TypeBroad incumbent
Description

AI-driven genomics and multimodal data analysis platform serving hospitals, labs, and pharma. Overlaps with BioTuring in multi-omics analysis and pharma R&D workflows but with a broader clinical/diagnostic orientation and larger installed base.

TypeEmerging player
Description

AI platform connecting multimodal biomedical data with pharma research workflows. Comparable to BioTuring's Talk2Data in curating and querying large-scale multi-omics datasets with AI/ML, though with a stronger focus on federated learning and biopharma partnership economics.

TypeEmerging player
Description

AI-driven immunology platform built on single-cell and multi-omics data, serving pharma drug discovery. Comparable to BioTuring's cell-type annotation and pharma positioning, with a deeper immunology-specific focus.

TypeDirect peer
Description

Spatial biology and pathology image analysis software serving translational and clinical research. Directly comparable to BioTuring's SpatialX and pathology image annotation services for tissue-based spatial workflows.

10GenePattern / SeqGeq (Broad Institute / FlowJo)
TypeOthers
Description

Open-source and academic bioinformatics platforms (GenePattern) and SeqGeq single-cell analysis software target similar single-cell and multi-omics workflows as BioTuring, primarily through academic distribution channels.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioTuring

Bioinformatics Softwarebioturing.com

BioTuring is a San Diego bioinformatics software company (founded 2016) that sells an integrated ecosystem of platforms — BBrowserX Pro, SpatialX, Talk2Data, and SmartBulk — for single-cell, multi-omics, and spatial biology analysis, serving academic researchers and pharmaceutical enterprises globally.

What BioTuring does

BioTuring, Inc. is a San Diego-based bioinformatics software company founded in 2016 that develops an integrated ecosystem of platforms for single-cell, multi-omics, and spatial biology data analysis. Its product family includes BBrowserX Pro for large-scale single-cell RNA-seq analysis (handling 10M+ cells), SpatialX for spatial transcriptomics and proteomics, Talk2Data (a GPU-accelerated database of 500M+ curated single cells with natural-language agentic AI queries and Model-Context-Protocol interoperability on NVIDIA Blackwell B200 infrastructure), SmartBulk for bulk RNA-seq, BioVinci for visualization, BioStudio as an all-in-one notebook platform, BioTuring Lens for spatial deconvolution, and the BioFlex Python SDK for programmatic access. Underlying technology combines proprietary deep-learning algorithms (Venice, IC-VAE, MetaReference, AlphaSC) with multi-stage data curation pipelines standardized on EBI Cell Ontology, Mondo Disease Ontology, and UBERON.

The company serves individual academic researchers, postdoctoral fellows, and professors at universities and academic medical centers (Chiba University, Stanford Medicine, MD Anderson, University of Tokyo, CWRU, University of Hawaii) alongside enterprise customers including pharmaceutical companies (Sanofi, via the Sanofi Browser on Talk2Data for neurodegenerative disease datasets) and biotech services firms (Argentys). BioTuring is certified to ISO/IEC 27001 (2019) and ISO/IEC 27701 (2022).

BioTuring generates revenue primarily through annual software subscriptions across multiple Subscription Levels (SaaS, private-cloud, on-premise), tiered project-based data curation services (price tiers from under $20k to over $1M covering spatial, single-cell, pathology, bulk, and ATAC-Seq annotation), and professional services for implementation, training, and support. Go-to-market blends a product-led growth motion with free trials and self-serve access for individual researchers, complemented by enterprise field sales for pharmaceutical and large research institution contracts. The company is privately held, CEO-led by Son Pham, with only $1,020,677 in disclosed funding from October 2017.

BioTuring firmographics

Firmographics
Name
BioTuring
Legal name
BioTuring, Inc.
Website
https://bioturing.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
BioTuring is a San Diego bioinformatics software company (founded 2016) that sells an integrated ecosystem of platforms — BBrowserX Pro, SpatialX, Talk2Data, and SmartBulk — for single-cell, multi-omics, and spatial biology analysis, serving academic researchers and pharmaceutical enterprises globally.
Ownership category
akta.pro rank

BioTuring industry classification

Industry
Product category
Bioinformatics Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Single-cell analysis software
  • Spatial biology platform
  • Multi-omics data analysis
  • Bioinformatics visualization tools
  • RNA sequencing analytics

Where BioTuring is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BioTuring business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Software Subscriptions: BioTuring grants customers limited, non-exclusive, non-transferable, non-sublicensable subscription rights to access and use the software platforms (BBrowserX, SpatialX, Talk2Data, SmartBulk, BioVinci) during a defined subscription term. Subscriptions are assigned to specific customer or Authorized User accounts and may include various Subscription Levels with different feature entitlements, user counts, storage parameters, and support scope. Fees are non-cancellable and non-refundable once paid, with invoices due within 30 days.
  2. Professional Services: Implementation, onboarding, maintenance, support, training, hosting, migration, storage, compute, and related professional or technical services provided under separate Order Forms. Custom implementations, bespoke onboarding, and expanded support scope are billed separately through Order Forms.
  3. Data Curation Services: Tailored data curation solutions for biological data including radiological imaging, spatial omics, single-cell annotation, pathology image annotation, bulk annotation, and ATAC-Seq curation. Pricing is project-based with tiers: <$20k, $20k-100k, $100k-1M, $1M+.
  4. Trial Services: Trial, proof-of-concept, sandbox, pilot, evaluation, or no-charge access to software or services provided for customer internal evaluation purposes. Trial services are modified or limited at BioTuring's discretion and do not include service commitments or enhanced support obligations.
  5. Data Storage Services: Right to store and process Customer Data in specified amounts and retention profiles as identified in Order Forms or Subscription plans, with additional storage billed separately.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractData Curation Services - Project Budget Tiers
SubscriptionAnnualSubscription Levels
FreemiumPay-as-you-goTrial Services

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

BioTuring product offering

Product offering

Core offering

BioTuring develops and sells a suite of bioinformatics software platforms for analyzing single-cell, spatial, and bulk RNA-sequencing data. Its core offerings include BBrowserX Pro for large-scale single-cell analysis, SpatialX for spatial biology data, Talk2Data as a GPU-accelerated database of 500M+ curated single cells, and SmartBulk for bulk RNA-seq analysis, complemented by professional data curation services.

Product overview

BioTuring offers a unified ecosystem of bioinformatics platforms and services for multi-omics and spatial biology analysis. The core portfolio includes BBrowserX Pro for large-scale single-cell RNA-sequencing analysis (handling 10M+ cells), SpatialX for spatial biology data analysis with cell annotation, Talk2Data as a GPU-accelerated database of 500M+ curated single-cell profiles with natural language AI queries, and SmartBulk for bulk RNA-sequencing analysis. Additional products include BioVinci for visualization, BioStudio as an all-in-one bioinformatics platform, BioTuring Lens for spatial deconvolution, and the BioFlex SDK for programmatic access. The ecosystem is complemented by data curation services including spatial annotation, single-cell annotation, pathology image annotation, bulk annotation, and ATAC-Seq annotation. The company holds ISO/IEC 27001 and ISO/IEC 27701 certifications and has partnered with industry leaders including Sanofi for the Sanofi Browser collaboration on Talk2Data.

Differentiator

Problem solved

Functional benefit

Brands

  • BBrowserX Pro: An all-in-one platform for analysis of single-cell RNA-sequencing data with advanced tools for cell type annotation, DGE analysis, and cell-cell communication
  • SpatialX
  • Talk2Data
  • SmartBulk
  • BioVinci
  • BioStudio
  • BioTuring Lens
  • BioFlex SDK

Products and services

  • BBrowserX Pro An all-in-one platform for analyzing single-cell RNA-sequencing data, handling giga-scale studies exceeding 10M cells with integrated annotation, automated cell type prediction, differential gene expression analysis, pathway enrichment, cell-cell communication analysis, pseudotime/trajectory analysis, and cancer cell prediction modules. Designed for biomedical researchers and scientists.
  • SpatialX A platform for analyzing spatial biology data with cell annotation, enabling exploration of spatial transcriptomics data within tissue architecture context. Features a Windows-based, non-coding interface allowing biologists to interpret spatial data and understand cell-to-cell interactions at single-cell transcriptomics level.
  • Talk2Data A GPU-accelerated multi-omics database providing real-time analysis of 500M+ curated single cells across multiple omics layers. Features natural language queries with agentic AI trained on biomedical knowledge, BioFlex SDK for programmatic access, and Model-Context-Protocol interoperability for AI agent integration.
  • SmartBulk An intuitive platform for analyzing bulk RNA-sequencing data, enabling identification of differentially expressed genes, enriched pathways, sample clustering, and cell-type deconvolution. Includes PCA analysis and functional enrichment capabilities.
  • BioFlex SDK A Python-based software development kit providing programmatic access to Talk2Data datasets, enabling execution of analyses and embedding BioTuring platform capabilities into custom computational pipelines.
  • Data Curation Services Professional data curation services including Spatial Annotation Service, Single-Cell Annotation Service, Pathology Image Annotation Service, Bulk Annotation Service, and ATAC-Seq Annotation Service. Services organize, normalize, and annotate biological data using standardized ontologies for downstream analysis. Priced by project budget tiers from under $20k to over $1M.

Quantifiable outcome

  • Handles giga-scale studies exceeding 10M cells while staying responsive
  • +3 more outcomes

Companies that use BioTuring

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

BioTuring technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature13 records

BioTuring partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SanoficoreStrategic or Co-development PartnerBioTuring hosts the Sanofi Browser on its Talk2Data platform, providing access to Sanofi's published single-cell transcriptomic datasets (5 studies with 297,364 cells total) focused on neurodegenerative disease research including ALS, multiple sclerosis, and Parkinson's disease models. The collaboration enables researchers to explore Sanofi's published datasets including microglia ferroptosis studies (Ryan et al.), BTK inhibitor research (Gruber et al.), and RIPK1 signaling studies in ALS (Zelic et al.).

Scale indicators17 records

Recent moves6 records

Expansion highlights5 records

BioTuring competitors and assessment

Company assessment

Direct peers

  • Partek (Illumina): Direct competitor in single-cell and bulk RNA-seq analysis software. Now owned by Illumina, Partek offers FlowJo and Partek Flow with similar cell-type annotation, DGE, and visualization capabilities targeted at bench scientists without heavy coding requirements.
  • Qlucore: Direct peer in GUI-driven omics analysis software for life sciences. Qlucore offers multi-omics, single-cell, and spatial visualization tools with a similar non-coding positioning aimed at biologists and translational researchers.
  • Dotmatics: Scientific informatics platform serving biology R&D with data analysis, visualization, and ELN capabilities. Overlaps with BioTuring on multi-omics data analysis and pharma/biotech enterprise workflows, with broader lab informatics scope.
  • Biomage (now part of Parse Biosciences): Cloud-based single-cell RNA-seq analysis platform directly competing with BBrowserX Pro. Acquired by Parse Biosciences, Biomage targets bench scientists with no-code analysis workflows similar to BioTuring's positioning.
  • Visiopharm: Spatial biology and pathology image analysis software serving translational and clinical research. Directly comparable to BioTuring's SpatialX and pathology image annotation services for tissue-based spatial workflows.

Emerging players

  • LatchBio: Cloud-native bioinformatics platform offering data management, analysis pipelines, and AI tools for multi-omics and biomedical data. Overlaps with BioTuring's Talk2Data and BioStudio offerings with a stronger developer/AI-agent focus.
  • Owkin: AI platform connecting multimodal biomedical data with pharma research workflows. Comparable to BioTuring's Talk2Data in curating and querying large-scale multi-omics datasets with AI/ML, though with a stronger focus on federated learning and biopharma partnership economics.
  • Immunai: AI-driven immunology platform built on single-cell and multi-omics data, serving pharma drug discovery. Comparable to BioTuring's cell-type annotation and pharma positioning, with a deeper immunology-specific focus.

Broad incumbents

  • SOPHiA Genetics: AI-driven genomics and multimodal data analysis platform serving hospitals, labs, and pharma. Overlaps with BioTuring in multi-omics analysis and pharma R&D workflows but with a broader clinical/diagnostic orientation and larger installed base.

Others

  • GenePattern / SeqGeq (Broad Institute / FlowJo): Open-source and academic bioinformatics platforms (GenePattern) and SeqGeq single-cell analysis software target similar single-cell and multi-omics workflows as BioTuring, primarily through academic distribution channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

BioTuring social profiles

Digital presence

BioTuring compliance and trust

Trust signal

Compliance2 records

BioTuring financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioTuring leadership team

Management profile

Number of profiles

Profiles1 record

BioTuring funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioTuring M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioTuring

What does BioTuring do?

BioTuring develops and sells a suite of bioinformatics software platforms for analyzing single-cell, spatial, and bulk RNA-sequencing data. Its core offerings include BBrowserX Pro for large-scale single-cell analysis, SpatialX for spatial biology data, Talk2Data as a GPU-accelerated database of 500M+ curated single cells, and SmartBulk for bulk RNA-seq analysis, complemented by professional data curation services.

Is BioTuring a public or private company?

BioTuring is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BioTuring founded?

BioTuring was founded in 2016. It employs 51 to 100 people.

Where is BioTuring based?

BioTuring is headquartered in San Diego, United States, in the North America region.

How does BioTuring make money?

Five revenue lines are on record. Software Subscriptions are the primary driver. The others are professional Services, data Curation Services, trial Services and data Storage Services.

Who are BioTuring's main competitors?

Direct peers on record are Partek (Illumina), Qlucore, Dotmatics, Biomage (now part of Parse Biosciences) and Visiopharm. Emerging players are LatchBio, Owkin and Immunai. SOPHiA Genetics is listed as a broad incumbent. GenePattern / SeqGeq (Broad Institute / FlowJo) is listed as an others.

Does BioTuring have an API?

Yes. Talk2Data provides the BioFlex SDK for programmatic access to datasets, running analyses, and embedding Talk2Data into custom computational pipelines. Talk2Data also offers Model-Context-Protocol interoperability for AI agent integration. The SDK enables programmatic access to 500M+ curated single-cell and multi-omics profiles. Developer documentation is at bioturing.com/documentation.

What industry is BioTuring in?

BioTuring's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals